300363: Porton Pharma Solutions Ltd. - Summary | Jitta

Porton Pharma Solutions Ltd.

CHN:300363

Price
CN¥21.21
Loss Chance
49.2%
4.27JITTA SCORE
> 1,000%Over Jitta Line
Jitta Ranking
158 / 487
1,496 / 5,259
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (54)
Recent Business Performance (74)
Financial Strength (72)
Return to Shareholders (21)
Competitive Advantage (44)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Revenue and EarningEarning loss detected in 2024
Operating MarginInconsistent
Debt LevelVery High Long Term Debt
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
4.27
> 1,000%
4.42
> 1,000%
4.24
> 1,000%
Pharmaceuticals
6.36
2.64%
5.47
25.22%
7.76
43.10%
COMPANY DESCRIPTION
Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial in China and internationally. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain. It also offers crystallization, bio catalysis, metal catalysis, flow chemistry, prep-chromatography, and milling. Porton Pharma Solutions Ltd. was formerly known as Porton Fine Chemicals Ltd. and changed its name to Porton Pharma Solutions Ltd. in January 2018. The company was incorporated in 2005 and is headquartered in Chongqing, China.